Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$653M |
| 2 |
Amazon
AMZN
|
+$602M |
| 3 |
ExxonMobil
XOM
|
+$473M |
| 4 |
Tesla
TSLA
|
+$437M |
| 5 |
Starbucks
SBUX
|
+$380M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class A
BRK.A
|
+$511M |
| 2 |
Netflix
NFLX
|
+$427M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$397M |
| 4 |
Nike
NKE
|
+$373M |
| 5 |
Microsoft
MSFT
|
+$365M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.68% |
| 2 | Healthcare | 17.69% |
| 3 | Consumer Discretionary | 13.09% |
| 4 | Industrials | 7.96% |
| 5 | Consumer Staples | 7.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GURE
3001
Gulf Resources
GURE
$4.85M
| $291K | ﹤0.01% |
17,649
-1,380
| -7% | -$22.3K |
|
|
SCTL
3002
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
| $291K | ﹤0.01% |
831,217
-4,800
| -0.6% | -$1.75K |
|
3003
Mannatech
MTEX
$9.24M
| $290K | ﹤0.01% |
35,799
-1,600
| -4% | -$14.3K |
|
3004
NuScale Power
SMR
$4.03B
| $290K | ﹤0.01% |
+88,200
| New | +$313K |
|
3005
Dimensional US Targeted Value ETF
DFAT
$14.7B
| $288K | ﹤0.01% |
5,500
-9,900
| -64% | -$463K |
|
3006
electroCore
ECOR
$72.9M
| $288K | ﹤0.01% |
48,416
+5,800
| +14% | +$33.3K |
|
3007
Coffee Holding Co
JVA
$20M
| $288K | ﹤0.01% |
315,964
-6,000
| -2% | -$4.82K |
|
|
SWKH
3008
DELISTED
SWK Holdings
SWKH
| $287K | ﹤0.01% |
20,697
+1,893
| +10% | +$24.7K |
|
3009
Educational Development Corp
EDUC
$11.8M
| $285K | ﹤0.01% |
245,545
+2,800
| +1% | +$2.7K |
|
3010
Replimune Group
REPL
$1.01B
| $285K | ﹤0.01% |
33,853
-52,847
| -61% | -$613K |
|
3011
ARS Pharmaceuticals
SPRY
$612M
| $285K | ﹤0.01% |
52,000
-85,700
| -62% | -$375K |
|
3012
Western Union
WU
$2.21B
| $285K | ﹤0.01% |
+23,921
| New | +$292K |
|
3013
Broadwind
BWEN
$109M
| $282K | ﹤0.01% |
101,700
-5,928
| -6% | -$15.7K |
|
3014
Acushnet Holdings
GOLF
$5.46B
| $278K | ﹤0.01% |
4,400
-67,000
| -94% | -$3.76M |
|
|
WIMI
3015
WiMi Hologram Cloud
WIMI
$24.5M
| $278K | ﹤0.01% |
34,360
-160
| -0.5% | -$1.09K |
|
3016
Compass Therapeutics
CMPX
$387M
| $276K | ﹤0.01% |
176,799
+149,999
| +560% | +$260K |
|
3017
Retractable Technologies
RVP
$20.1M
| $276K | ﹤0.01% |
248,574
+40,310
| +19% | +$45.1K |
|
|
NRGD
3018
DELISTED
MicroSectors US Big Oil -3x Inverse Leveraged ETN
NRGD
| $276K | ﹤0.01% |
1,200
-500
| -29% | -$117K |
|
|
NFGC
3019
New Found Gold
NFGC
$641M
| $275K | ﹤0.01% |
+78,700
| New | +$298K |
|
3020
Dave Inc
DAVE
$4.06B
| $274K | ﹤0.01% |
+32,700
| New | +$204K |
|
|
SDPI
3021
DELISTED
Superior Drilling Products Inc.
SDPI
| $273K | ﹤0.01% |
381,810
-133,431
| -26% | -$98K |
|
|
TEAD
3022
Teads Holding Co
TEAD
$66.9M
| $272K | ﹤0.01% |
62,000
-18,300
| -23% | -$77.5K |
|
|
AKTS
3023
DELISTED
Akoustis Technologies Inc
AKTS
| $272K | ﹤0.01% |
325,900
-280,758
| -46% | -$189K |
|
3024
Biglari Holdings Class A
BH.A
$1.21B
| $270K | ﹤0.01% |
340
+10
| +3% | +$7.73K |
|
3025
Humacyte
HUMA
$194M
| $270K | ﹤0.01% |
95,100
-12,400
| -12% | -$31.8K |
|
Similar funds
Renaissance Technologies's Q4 2023 Portfolio in Review
As of Q4 2023, Renaissance Technologies held 4,318 positions worth $64.6B, up 10% from $58.7B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies's Q4 2023 filing shows 702 new, 1,590 increased, 1,355 reduced and 633 closed positions. Its largest new stake was Amazon: 4,296,466 shares worth $653M. The largest sale was Berkshire Hathaway Class A, an estimated $511M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Renaissance Technologies's largest Q4 2023 buy was Amazon: 4,296,466 shares worth $653M.
- Renaissance Technologies added most to Meta Platforms (Facebook) in Q4 2023, an estimated $653M increase.
- Renaissance Technologies's biggest Q4 2023 reduction was Berkshire Hathaway Class A, cutting an estimated $511M.
- Renaissance Technologies fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $397M.
- Renaissance Technologies's ten largest holdings make up 12% of its $64.6B portfolio in Q4 2023.
- Renaissance Technologies opened 702 new positions and closed 633 in Q4 2023.
- Renaissance Technologies's portfolio value rose 10% quarter-over-quarter to $64.6B.
Based on Renaissance Technologies's 13F filing for Q4 2023, filed 13 Feb 2024.